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Abstract
We investigated mechanisms for inducing focal adhesion kinase (FAK) tyrosine phosphorylation and their ability to trigger MAP kinase
signaling using transmembrane chimeras that localize FAK and its mutants to the plasma membrane. We tested whether tyrosine
phosphorylation was triggered by FAK transmembrane aggregation using antibodies against the chimeric extracellular domain. Experimental
clustering of chimeras containing integrin h cytoplasmic domains or FAK induced FAK tyrosine phosphorylation and trans-phosphorylation
of endogenous FAK, as well as strong ERK activation. Next, we examined whether lower-order molecular proximity, namely dimerization,
could regulate FAK tyrosine phosphorylation. We found that even relatively low-affinity FAK dimerization (Kd = 3.9 10 5 M), in either of
two different orientations, could induce FAK tyrosine phosphorylation. However, this cytoplasmic FAK dimerization could not induce MAP
kinase activation or trans-phosphorylation of endogenous FAK. We conclude that dimerization of FAK is sufficient to induce its tyrosine
phosphorylation, but that higher-order molecular proximity (clustering) at the cell membrane is apparently needed for additional biochemical
events. This study identifies a proximity mechanism for regulating the initiation of FAK-mediated biochemical signaling.
Published by Elsevier Science B.V.
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1. Introduction
Functions of integrin receptors and of the cytoskeleton in
signal transduction are receiving increasing attention as
evidence for their roles in triggering or modulating cellular
signaling pathways has accumulated (for recent reviews, see
Refs. [1–15]). Transmembrane signal transduction by integ-
rins can regulate cellular functions as diverse as cell shape,
migration, gene expression, growth, differentiation, and
apoptosis. Rapid signaling processes activated by integrins
include tyrosine phosphorylation of focal adhesion kinase
(FAK), activation of mitogen-activated protein kinase
(MAPK) pathways involving both extracellular signal-regu-
lated kinase (ERK) and c-Jun amino-terminal kinase (JNK),
and changes in membrane fluxes of divalent cations and
hydrogen ions.
The precise mechanisms by which integrins transduce
events such as the activation of MAPKs remain to be
established. Previous studies have indicated that MAPKs
can be activated by integrin aggregation, in the absence of
integrin occupancy [16,17]. Leading candidates for mecha-
nisms of activation include FAK phosphorylation by Src
family members and binding of Grb2, or alternatively, the
linkage of Grb2 to integrins via Shc in a FAK-independent
process [18–21]. Integrin-mediated activation of the ERK
pathway has been described as Ras-dependent, Ras-inde-
pendent, and/or Rho-dependent [22–24], with some differ-
ences possibly due to cell type. A major factor contributing
to the complexity of integrin-mediated signaling is the fact
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that integrin-mediated cell contact with extracellular mole-
cules result in the accumulation of a number of proteins into
large complexes of cytoskeletal and signaling molecules
[3,5,6,25]. These multimolecular complexes that form early
after cell contact with ligand- or anti-integrin-coated beads
can include not only cytoskeletal proteins such as talin,
tensin, a-actinin, and F-actin, but also a total of over 20
signaling molecules such as FAK, Src family kinases,
phosphatidylinositol 3V-kinase, and Ras.
An initial approach to dissecting integrin signaling
mechanisms was to study the function of isolated integrin
cytoplasmic domains. When expressed as chimeras with
extracellular reporter domains such as the IL-2 receptor a
(tac) subunit or CD4, integrin h subunit cytoplasmic tails
can localize to focal contacts, stimulate FAK phosphoryla-
tion especially when clustered, and even function as dom-
inant-negative inhibitors of cell adhesion [26–29]. Their
effects vary depending on the type of cytoplasmic domain.
They are likely to mediate interactions with many cytoplas-
mic structural and signaling molecules (for review see Ref.
[30]), which makes understanding the pathways of activa-
tion more difficult.
A theoretically more focused and systematic approach
would be to express an individual cytoplasmic molecule that
is a candidate for a key signaling intermediate, then to
examine whether localizing it to the plasma membrane or
clustering it is sufficient for its activation, and for inducing
downstream signaling events. Simple membrane localiza-
tion of Raf-1 can promote its activation [31], and over-
expression of FAK linked to the extracellular and
transmembrane domains of CD2 can result in its phosphor-
ylation, suppression of apoptosis, and anchorage-independ-
ent cell growth [32–34]. Although one interpretation of
the latter results is that localization adjacent to the plasma
membrane is itself sufficient to activate FAK, an alter-
native explanation is that local high concentrations of FAK
close to the membrane leads to activation and other
downstream effects. Indeed, it has been demonstrated that
overexpression of FAK can induce MAPK activation
[35,36].
We previously demonstrated that FAK could be detected
in substantial quantities in integrin-induced adhesion com-
plexes, if integrins were aggregated in the absence of ligand
occupancy, even if tyrosine phosphorylation was selectively
inhibited by genistein or herbimycin A [17]. In this study,
we tested directly the regulation of FAK by membrane
translocation and clustering using transmembrane chimeras
of FAK and its mutants. We also addressed questions related
to the regulation of its tyrosine phosphorylation and down-
stream signaling by low-order aggregation utilizing a novel
dimerization system based on modified leucine zippers [37].
We found that simple cell surface expression and membrane
localization of FAK in NIH 3T3 cells, tethered to the
membrane by the IL-2 receptor extracellular and transmem-
brane domains, neither induces its phosphorylation nor
MAPK activation involving the ERK pathway. In contrast,
clustering of the FAK chimera using beads coated with an
antibody to the IL-2 receptor extracellular domain produced
ERK activation, prolonged substantially beyond the typical
integrin-induced response. We also observed trans-phos-
phorylation of endogenous FAK by clustered, activated
chimeric FAK.
Next, we examined directly whether low-order molec-
ular proximity (dimerization) could also promote FAK
phosphorylation. We found that relatively low-affinity
dimerization of FAK (Kd = 3.9 10 5 M) in parallel or
tandem orientations could promote FAK phosphorylation.
We conclude that molecular proximity can control the
levels of FAK phosphorylation, and that higher-order
transmembrane clustering can induce MAPK activation
and FAK trans-phosphorylation, all independent of cell
adhesion.
2. Materials and methods
2.1. Construction of chimeric receptors
Chimeric transmembrane receptors were constructed
using standard methods [38]. The sequences of all con-
structs were confirmed by nucleotide sequencing, and
protein expression from the constructs described in this
study was confirmed after transfection using immunopre-
cipitation or Western immunoblotting. The general
approach to generate a chimera with each type of cyto-
plasmic domain was to insert partial or full-length cDNA
molecules into HindIII–XhoI or HindIII–XbaI restriction
sites of the plasmid vector pCMV/IL-2R. This vector is
driven by the CMV promoter, and it expresses the extrac-
ellular and transmembrane domains of the non-signaling a
subunit of the interleukin-2 receptor (IL-2R) as a fusion
protein with any molecule of interest as the cytoplasmic
domain [28].
Mouse FAK cDNA clone (pT7-7-FAK) was obtained
from American Type Culture Collection (Manassas, VA).
Full-length mouse FAK cDNA was inserted into pCMV/
IL-2R as follows: a PCR product encoding the first 500 bp
of FAK cDNA was generated using pT7-7-FAK as tem-
plate with a primer containing a HindIII site followed by
15 nt encoding the first 5 amino acids of FAK (GenBank
MUSFAK, residue 110): 5V-GGCTAGAAGCTTATGG-
CAGCTGCTTAT-3V, and the anti-sense primer 5V-GGTGC-
TTCTAGAGGTCTACTTGATCAGC-3Vcoding for nt
586–602 followed by an XbaI site. The PCR product
was ligated into CMV/IL-2R using its HindIII and XbaI
sites. An AccI–XbaI fragment was then removed from the
ligation product and replaced by an AccI–XbaI fragment
from pT7-7-FAK, creating a full-length IL-2R/FAK chi-
mera that included the FAK 3Vnon-translated region. The
FAK454R mutant was generated by converting codon 454
encoding lysine to an arginine residue, and FAK397F and
FAK925F were obtained by replacing the tyrosine resi-
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due corresponding to amino acid positions 397 or 925
with a phenylalanine residue, using PCR-directed muta-
genesis [38]. Mutations were confirmed by DNA se-
quencing.
2.2. Construction of expression vectors encoding leucine
zipper fusion proteins
Full-length murine FAK cDNA was incorporated into
pcDNA3 expression vectors (Invitrogen, Carlsbad, CA)
containing sequences coding for different epitope tags. An
expression vector containing full-length chicken vinculin
was kindly provided by B. Geiger (Weizmann Institute of
Science, Rehovot, Israel). Leucine zippers were amplified
by PCR using Vent polymerase (New England Biolabs,
Beverly, MA) using previously described templates [37].
Leucine zipper PCR products were ligated into the appro-
priate expression vectors using standard molecular biology
techniques [37,38].
2.3. Cells and transfections
NIH 3T3 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 1 mM
glutamine, 50 Ag/ml streptomycin, 50 U/ml penicillin,
and 10% heat-inactivated bovine serum (BioWhittaker,
Walkersville, MD). Electroporation of these cells was
performed as previously described at 170 V and 960 AF
with a Bio-Rad GenePulser (Hercules, CA), but without
any thymidine block [28]. Transfections were performed
using 30 Ag DNA for each chimeric IL-2R/cytoplasmic
protein construct, 5 Ag/ml pcDNA3 containing HA-ERK2
DNA, or 5 Ag/ml pcDNA3 containing Ras N17 DNA
[39]. For expression of leucine zipper fusion proteins,
sub-confluent cultures of NIH 3T3 cells in 100 mm tissue
culture dishes were transfected with 3 Ag of purified
DNA and 30 Al of Lipofectamine (Life Technologies,
Grand Island, NY), according to the manufacturer’s
protocol.
2.4. Immunological reagents
For clustering chimeras, latex beads were coated with
mouse monoclonal antibody 7G7/B6 against human IL-2
receptor (Upstate Biotechnology, Lake Placid, NY). Mouse
monoclonal antibody 12CA5 to HA epitope was purchased
from Boehringer Mannheim (Indianapolis, IN). Mouse
monoclonal antibody against FAK was purchased from
Transduction Laboratories (Lexington, KY), and mouse
monoclonal antibody against AU5 epitope was from
BAbCO (Berkeley, CA). For immunoprecipitation, agar-
ose-conjugated anti-phosphotyrosine antibody 4G10 was
obtained from Upstate Biotechnology. Polyclonal anti-
human ERK2 antibody used in Western blotting to deter-
mine levels of expression of HA-ERK2 was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA).
2.5. Measurement of ERK activation
Latex beads (1107; mean diameter 11.9 Am; Sigma, St.
Louis, MO) were coated with 10 Ag anti-human IL-2
receptor antibody 7G7/B6 as described previously [17].
After electroporation and cell culture of NIH 3T3 cells for
2 days, the cells were detached with trypsin-EDTA, allowed
to recover in complete medium containing 10% bovine
serum and 25 Ag/ml cycloheximide (to block fibronectin
synthesis and secretion) for 20 min at 37 jC, then washed
and incubated in serum-free medium containing 25 Ag/ml
cycloheximide for 30 min. Cells (1106) in 500 Al were
incubated with 1107 beads at 37 jC. For measurement of
ERK activity, cells were extracted at the indicated times
with 1% NP-40, 20 mM HEPES, pH 7.5, 10 mM EGTA, 40
mM h-glycerophosphate, 2 mM Na3VO4, 1 mM DTT, 2.5
mM MgCl2, 20 Ag/ml aprotinin, 20 mg/ml leupeptin, 1 mM
PMSF. HA-ERK2 protein was immunoprecipitated at 4 jC
using anti-HA monoclonal antibody 12CA5 for 2 h, fol-
lowed by protein G-Sepharose for 1 h. The complexes were
washed once with PBS containing 1% NP-40 and 2 mM
Na3VO4, once with buffer (100 mM Tris, pH 7.5, 500 mM
LiCl), then once with kinase reaction buffer (12.5 mM
MOPS, pH 7.5, 12.5 mM h-glycerophosphate, 7.5 mM
MgCl2, 0.5 mM EGTA, 0.5 mM NaF, 0.5 mM Na3VO4).
For measuring ERK activity, HA-ERK2 immunocom-
plexes were incubated with kinase reaction buffer contain-
ing 1 ACi g32P-ATP, 20 mM unlabeled ATP, 3.3 mM DTT,
and 1.5 mg/ml myelin basic protein (MBP; Sigma) as a
substrate for ERK at 30 jC for 20 min. The reaction
mixtures were then suspended in Laemmli sample buffer,
heated at 100 jC for 5 min, and analyzed by SDS-PAGE.
Using gel slices, radioactivity was determined with a liquid
scintillation counter (LS 6000IC, Beckman, Palo Alto, CA).
Alternatively, ERK activation was also evaluated using anti-
phospho-ERK polyclonal antibody, according to the manu-
facturer’s instructions (Promega, Madison, WI).
2.6. Flow cytometry
In order to quantify the expression of the chimeras,
transfected cells were harvested by gentle trypsinization,
allowed to recover in DMEM with 10% bovine serum and
25 Ag/ml cycloheximide for 20 min at 37 jC, washed with
PBS, incubated with a 1/50 dilution of FITC-conjugated rat
anti-human IL-2 receptor antibody MCA 350F (Serotec,
Raleigh, NC) for 30 min at ambient temperature, washed
with PBS, fixed with 2% paraformaldehyde in PBS, and
then analyzed using a Becton Dickinson FACScan flow
cytometer.
2.7. Immunoprecipitation and Western immunoblotting
Chimeric receptors expressed on transfected cells were
clustered with anti-IL-2R antibody coated on beads, then the
cells were rinsed with PBS containing 1 mM sodium
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orthovanadate and lysed with RIPA buffer (1% Triton X-
100, 1% sodium deoxycholate, 0.1% SDS, 150 mM NaCl,
50 mM Tris pH 8.0, 20 Ag/ml aprotinin, 2 Ag/ml leupeptin, 1
Ag/ml pepstatin A, 2 mM phenylmethylsulfonyl fluoride
(PMSF), 1 mM sodium orthovanadate). The protein extracts
were subjected to SDS polyacrylamide gel electrophoresis
and Western immunoblotting. Immunoprecipitation and
Western immunoblotting for leucine zipper fusion proteins
were performed in a similar manner. In order to compare
relative expression levels of HA-ERK2, cells were extracted
with RIPA buffer and then subjected to SDS gel electro-
phoresis and Western immunoblotting with anti-HA anti-
body.
3. Results
3.1. ERK activation mediated by clustering of chimeric
molecules
Cell adhesive interactions with tissue culture substrates
or with beads coated with extracellular matrix ligands such
as fibronectin induce the transmembrane aggregation of a
variety of cytoskeletal and signaling molecules, as well as
initiating biochemical signaling that includes tyrosine phos-
phorylation of FAK and the activation of serine/threonine
MAP kinases. Integrin activation of ERK occurs in a pattern
that is transient, but which generally appears more pro-
longed than that induced by growth factor receptors [16–
18,40,41]. Molecular proximity (clustering or dimerization)
of cytoplasmic domains controls the activities of growth
factor receptors [42]. We therefore examined whether integ-
rin-mediated MAP kinase signaling could be triggered by
simple clustering of integrin cytoplasmic tails.
We first examined the ability of single-subunit chimeric
receptors containing different individual integrin h cyto-
plasmic domains to mimic integrin-mediated induction of
ERK activation. Chimeric receptors consisting of the integ-
rin h1, h3, or h5 cytoplasmic domains [28] connected to the
extracellular and transmembrane domains of the small, non-
signaling a subunit of the human IL-2R were transiently
expressed in NIH 3T3 fibroblasts. ERK2 containing a
hemagglutinin tag (HA-ERK2) was co-transfected to mon-
itor activation of the ERK MAPK signaling pathway. The
doubly transfected cells were then incubated with beads
coated with anti-IL-2R antibodies to cluster the chimeric
receptors, and the activation of ERK was examined with an
in vitro kinase assay for activation of the co-transfected HA-
ERK2 precipitated with anti-HA antibody. All of the experi-
ments were performed using suspended cells, in order to
avoid complications of signaling events mediated by cell
adhesion.
ERK2 activation triggered by clustering of each of these
integrin h chimeric receptors was observed consistently at
10 min, became maximal at 30 min, and then dissipated by
60 min (Fig. 1 for h1 and additional data not shown for h3
and h5). This pattern appeared identical to that previously
observed with intact integrins (e.g., see Ref. [17]). The same
time course and activity of these transfected h1, h3, or h5
intracellular domain chimeras observed in NIH 3T3 cells
was observed using primary human foreskin fibroblasts
(data not shown). As described previously for intact integ-
rins [17], co-clustering of FAK was observed by immuno-
fluorescence (not shown). Control experiments in NIH 3T3
cells and human foreskin fibroblasts examining for effects
of aggregation of IL-2R consisting of the extracellular and
transmembrane domains, but lacking any cytoplasmic
domain, could not induce ERK activation (Fig. 1A and data
not shown).
We next examined directly whether FAK clustering
might trigger signal transduction in the form of ERK
activation. We generated a chimeric molecule consisting
of the IL-2 extracellular and transmembrane domains fused
to cytoplasmic FAK. The chimera was transiently
expressed in NIH 3T3 cells. Forty-eight hours after trans-
fection, the cells were trypsinized and suspended, and the
ability of the chimeric FAK to activate ERK was measured
before and after aggregation by beads coated with anti-IL-
2R antibody. Chimeric receptors consisting of IL-2R and
intracellular FAK displayed little activation of ERK until
they were aggregated with antibody-coated beads (Fig.
1A). The time course of activation was rapid, but then
became prolonged, with high activation of ERK observed
from 10 min to periods as long as 120 min or longer (Fig.
1A). Effective expression of each of the transfected chi-
meric receptors was confirmed by Western immunoblot
analysis and quantitated by flow cytometry. The percentage
of expression of each chimeric receptor according to flow
cytometry ranged from 25% to 35% of the cells, and the
magnitude of each was similar regardless of the molecules
present as the cytoplasmic domain (Fig. 1B). We also
routinely confirmed that the expression of HA-ERK2 was
at similar levels in each type of transfected cell by Western
immunoblotting (data not shown). These results indicate
that (a) chimeric receptors consisting of the extracellular
IL-2R portion and different h integrin cytoplasmic domains
induce the activation of ERK with similar time courses as
native integrins, and (b) chimeric receptors with FAK as
the cytoplasmic domain induce activation of ERK after
clustering.
3.2. Tyrosine phosphorylation mediated by chimeric
receptors with FAK mutations
In order to explore which elements of the FAK protein
were required for the induction of its tyrosine phosphoryla-
tion upon clustering, chimeric receptors containing intra-
cellular domains consisting of mutated forms of FAK were
compared. The mutants included the mutation FAK454R
which replaces the well-conserved, catalytically essential
lysine 454 residue within its kinase domain, mutant
FAK397F which lacks the tyrosine phosphorylation site
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involved in binding of Src, and mutant FAK925F which lacks
the tyrosine phosphorylation site that mediates binding of
the adapter protein Grb2 (Fig. 2A). All of these FAK
mutants were used in previous studies [18,20,32,33].
Forty-eight hours after transfection of NIH 3T3 cells, the
phosphorylation of normal and mutated FAK chimeric
proteins were compared with each other and with endoge-
nous FAK molecules (Fig. 2).
Tyrosine phosphorylation of the chimeric FAK and
mutated FAK454R proteins was clearly observed from 10
to 120 min of clustering. Endogenous FAK was also
tyrosine phosphorylated from 10 to 120 min, in parallel
with exogenous chimeric FAK and FAK454R protein phos-
phorylation (Fig. 2B). At 10 and 60 min, tyrosine phosphor-
ylation of the mutated FAK molecules FAK397F and
FAK925F were also detected, accompanied by weak endog-
enous FAK tyrosine phosphorylation (Fig. 2C). In these
experiments, the expression of each chimeric receptor
ranged from 25% to 35% of total cells according to flow
cytometry (not shown). These results indicate that mem-
brane translocation of moderate levels of FAK are not
sufficient to induce FAK phosphorylation, unless accompa-
nied by transmembrane clustering. The clustering-mediated
induction of FAK phosphorylation and trans-phosphoryla-
tion of the endogenous FAK do not depend on the well-
conserved residue lysine 454.
3.3. FAK dimerization efficiently induces its tyrosine
phosphorylation, independent of cell adhesion
The experiments described above clearly indicate that
high-order molecular proximity (clustering) can induce FAK
tyrosine phosphorylation. It has been previously demon-
strated that low-order molecular proximity, namely dimeri-
zation, of cytoplasmic molecules such as ZAP70 or Raf-1
can also regulate biochemical responses [43,44]. We exam-
ined directly the role of dimerization in the regulation of
FAK phosphorylation. Two major strategies have been used
Fig. 1. Induction of MAPK activation by transmembrane clustering of cytoplasmic domains. (A) ERK2 activation was quantified in NIH 3T3 cells using
hemagglutinin-tagged ERK2 (HA-ERK2) co-transfected with chimeras consisting of the IL-2 receptor a subunit extracellular and transmembrane domains (IL-
2R) coupled to different cytoplasmic domains or molecules. Time courses of ERK2 activation after initiation of clustering (time = 0) of chimeric molecules
using extracellular beads coated with anti-IL-2R antibodies. Activation of ERK2 was observed after clustering chimeras containing either h1 cytoplasmic
domain (filled circles) or FAK (open squares). No activation above basal levels was observed in the absence of a cytoplasmic domain (IL-2R (–), open circles).
(B) Comparison of cell surface expression levels of the chimeric constructs. Aliquots of cells transfected with IL-2R alpha subunit chimeras containing the h1
cytoplasmic domain, no chimeric tail (control), or FAK were stained with anti-IL-2R to determine levels of expression and percentage of positive cells by flow
cytometry; solid line indicates immunofluorescence and dashed line indicates background fluorescence in the absence of the first antibody.
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previously to manipulate molecular proximity of membrane
receptors and cytoplasmic proteins: (a) chemical inducers of
dimerization (CIDs) [44,45], and (b) direct dimerization
based on leucine zippers [46]. We utilized modified leucine
zippers based on the vitellogenin gene binding protein
(VBP) as mediators of FAK dimerization [37].
The homo- and hetero-dimerization affinities of a pair of
VBP leucine zippers were manipulated by introducing point
mutations in their e and g positions (Fig. 3A). Thus, a
variety of leucine zippers with a wide range of homo- and
hetero-dimerization affinities were generated [37], and some
of them were utilized in the current study to mediate FAK
dimerization. The amino acid sequences and the heptad
organization of VBP leucine zipper forms ER34, EE34,
and RR34 are shown in Fig. 3B. These leucine zipper forms
were selected because of their different affinities for homo-
dimerization (Kd = 8.110 4 M and a melting temperature
of 21.6 jC for the EE34 form; Kd = 3.9 10 5 M and a
melting temperature of 27.1 jC for the RR34 form; and
Kd = 7.0 10 9 M and a melting temperature of 52.0 jC
for the ER34 form) [37]. The EE34 and the RR34 leucine
zippers form heterodimers with an affinity of Kd = 7 10 9
M and a melting temperature of 51.5 jC [37]. Different
combinations of leucine zippers were fused to FAK mole-
cules in the following experiments.
First, we examined whether leucine zippers can mediate
effective FAK dimerization. Two FAK constructs, each
containing a different epitope tag (HA or AU5), and both
fused to leucine zippers designed for high-affinity dimeriza-
tion were co-transfected into NIH 3T3 cells (Fig. 4A, part
2). Control cells were transfected with a mixture of two
FAK forms, each containing a different epitope tag, but only
one fused to the high-affinity leucine zipper (Fig. 4A, part
1). Forty-eight hours after transfection, the cells were trypsi-
nized and incubated in suspension for 1 h. In both sets of
transfections, the cells expressed equal amounts of HA or
AU5-tagged FAK molecules (Fig. 4B). When only one type
of tagged FAK was fused to the leucine zipper ER34, no co-
Fig. 2. FAK tyrosine phosphorylation induced by its trans-membrane clustering. (A) Schematic diagram of wild-type (top) and point mutations of FAK in the
kinase domain (residue 454 lysine to arginine), Src-binding site (residue 397 tyrosine to phenylalanine), and Grb2 binding site (residue 925 tyrosine to
phenylalanine). (B) and (C) Tyrosine phosphorylation patterns of FAK chimeras and endogenous FAK after clustering wild-type and mutated FAK chimeras as
determined by Western blotting for pTyr. The top band represents the exogenously introduced FAK chimeras with IL-2R ectodomain, and the lower band is
endogenous FAK, in cells transfected with the indicated chimeras. Control lanes show that no phosphorylation is observed after clustering molecules expressed
without any cytoplasmic domain (IL-2R (–)).
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precipitation of both types of tagged FAK was observed
(Fig. 4B, part 1). However, when both types of tagged FAK
contained the leucine zipper ER34 (designed to homo-
dimerize with high affinity, Kd = 7.0 10 9 M) immuno-
precipitation of the AU5-tagged FAK resulted in the
co-precipitation of the HA-tagged FAK (Fig. 4B, part 2).
This experiment demonstrates that leucine zippers can
mediate FAK dimerization. We also examined the local-
ization of the different forms of FAK within the cell. We
found that both HA-tagged FAK and HA-tagged FAK fused
to leucine zipper ER34 localized to focal contacts of NIH
3T3 cells plated on fibronectin in a manner similar that of
endogenous FAK (not shown).
Next, we examined whether dimerization could modu-
late the levels of FAK phosphorylation. NIH 3T3 cells
were transfected with control HA-tagged FAK, or with
HA-tagged FAK fused to leucine zipper ER34, which can
mediate FAK dimerization as established above. Forty-
eight hours after transfection, the cells were trypsinized
and incubated in suspension for 1 h. Then, immunopreci-
pitation for HA was performed, followed by Western blot
analysis for the HA epitope and phosphotyrosine (pTyr).
As shown in Fig. 5A, the cells expressed equal amounts of
HA-tagged FAK, but the pTyr levels of the dimerized form
were much higher. We observed nearly 4-fold increases in
FAK tyrosine phosphorylation upon dimerization (Fig.
5B). This experiment demonstrated that low-order molec-
ular proximity (dimerization) is sufficient to induce FAK
phosphorylation.
3.4. FAK phosphorylation can be induced by relatively low-
affinity dimerization, even in two different orientations
The wide range of available leucine zipper affinities
enabled us to examine whether high affinity or specific
orientation of dimerization is needed to induce FAK phos-
phorylation. As shown in Fig. 6A, HA-tagged FAK was
fused to different types of leucine zippers with different
homo-dimerization affinities. The plasmids were individu-
ally expressed in NIH 3T3 cells. Forty-eight hours after
transfection, the cells were incubated in suspension for 1 h,
then immunoprecipitation for the HA epitope was per-
formed. The levels of FAK tyrosine phosphorylation were
high when fused to the leucine zippers ER34 and RR34,
with affinities of Kd = 7.0 10 9 M and only Kd = 3.9
10 5 M, respectively. On the other hand, a zipper pair
with 20-fold lower affinity could not induce autophospho-
rylation (Fig. 6). This experiment indicates that even a rela-
tively low affinity of dimerization (lower than 10 5 M, but
higher than f 10  3 M) is sufficient to promote FAK
tyrosine phosphorylation. Interestingly, we did not detect
Fig. 4. Leucine zipper-mediated FAK dimerization. (A) NIH 3T3 cells were
co-transfected with HA-tagged FAK and AU5-tagged FAK fused to the
ER34 leucine zipper (1), or with HA-tagged FAK and AU5-tagged FAK,
both fused to ER34 leucine zippers (2). (B) Forty-eight hours following
transfection with combinations 1 or 2 as described in panel A, the cells were
trypsinized and incubated in suspension for 1 h, and then levels of FAK
proteins were evaluated by immunoprecipitation, followed by Western
blotting for AU5 and HA. Subsequently, Western blotting analysis for the
HA tag was performed on samples immunoprecipitated with anti-AU5
mAb. Note that FAK molecules with two different tags were co-
immunoprecipitated only when both were fused to the ER34 leucine zipper
designed for high affinity dimerization (Kd = 7.0 10 9 M; lane 2),
compared with control transfection (lane 1).
Fig. 3. Modified leucine zippers with differing dimerization affinities. (A)
Relative positions of the a–g residues within the VBP leucine zipper
heptads. The specificity and the affinity of leucine zipper dimerization are
controlled by interactions of the amino acid residues at positions e and g on
one leucine zipper with residues at positions gV and eV of its counterpart,
respectively [37]. (B) Amino acid sequences and four-heptad organization
of the leucine zippers used in this study. The underlined amino acids
indicate the wild-type VBP leucine zipper (ER34 form), and the
substitutions made to generate the EE34 and the RR34 forms.
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any ERK activation after transfecting the cells with highly
phosphorylated dimerized FAK/ER34 fusion (Fig. 6C).
Both leucine zipper-mediated dimerization and trans-
membrane clustering of FAK chimeras form aggregates in
which FAK molecules are positioned in a parallel orienta-
tion. Other studies have shown that activation of ZAP-70
by molecular proximity may depend on a single orientation
of the individual molecules within the dimer [43]. We
examined whether FAK hyper-phosphorylation mediated
by molecular proximity depends on a single, parallel
orientation. We utilized a unique combination of leucine
zipper/FAK fusions to promote tandem FAK dimerization
in order to examine whether an orientation other than
parallel can also promote its phosphorylation. Two types
of FAK molecules were co-expressed in NIH 3T3 cells:
one was HA-tagged and fused to the RR34 leucine zipper
at its C-terminus, and the other was Flag tagged and fused
to the EE34 leucine zipper at its N-terminus (Fig. 7A,
part 4).
The leucine zippers effectively mediated FAK dimeriza-
tion (Fig. 7B, lane 4) in a head-to-tail tandem orientation
of FAK molecules. As shown in Fig. 7B, tyrosine phos-
phorylation levels of FAK molecules fused to leucine
zippers mediating tandem dimerization (lane 4) were
higher (f 4-fold increase as evaluated by densitometry)
compared to controls (Fig. 7B, lanes 1–3 and 5).
We utilized the following controls in this experiment:
expression of FAK fused to the very low-affinity EE34
leucine zipper (Fig. 7A and B, lane 1); dimerization of FAK
and a control high molecular weight molecule, vinculin
(Fig. 7A and B, lane 2); co-expression of two types of
FAK molecules, only one fused to the low-affinity EE34
leucine zipper (Fig. 7A and B, lane 3); and co-expression of
two types of FAK molecules, both fused to the low affinity
EE34 leucine zipper (Fig. 7A and B, lane 5).
Fig. 6. Relatively low-affinity FAK dimerization can induce its hyper-
phosphorylation. (A) HA tagged FAK molecules were expressed alone or
fused to modified leucine zippers ER34 (with homo-dimerization affinity of
Kd = 8.110  4 M), RR34 (with homo-dimerization affinity of
Kd = 3.9 10  5 M), or ER34 (with homo-dimerization affinity of
Kd = 7.0 10 9 M). HA-tagged FAK without a zipper was used as a
control. (B) NIH 3T3 cells were transfected with FAK/leucine zipper
fusions or control non-fused FAK as indicated in panel A. Forty-eight hours
following transfection, the cells were trypsinized and incubated in
suspension for 1 h, followed by immunoprecipitation for the HA tag on
FAK. Samples were analyzed by Western blotting for HA or pTyr. A
notable increase in FAK phosphorylation was detected with both the RR34
and ER34 fusion proteins (lanes 3 and 4, respectively). (C) NIH 3T3 cells
were transfected with FAK/ER34 fusion (lane 3), constitutively activated
Ras V12 (lane 2) or non-transfected control (lane 1). Forty-eight hours later,
ERK activation was measured as described in Materials and methods.
Fig. 5. Leucine zipper-mediated dimerization induces FAK hyper-
phosphorylation. (A) NIH 3T3 cells were transfected either with HA-
tagged FAK (lane 1) or with HA-tagged FAK fused to the ER34 leucine
zipper (lane 2). Forty-eight hours following transfection, the cells were
trypsinized and incubated in suspension for 1 h, and then immunopreci-
pitation for HA-tagged FAK was performed. Samples were analyzed by
Western blotting for FAK or pTyr. Note that the dimerized form of FAK
(lane 2) contained a much higher level of pTyr (bottom panel) compared
with control, non-dimerized FAK (lane 1). (B) Quantitative evaluation of
hyper-phosphorylation of FAK induced by its dimerization. The phos-
phorylated FAK bands were quantitated by densitometry using NIH Image
software. The data shown represent the average of five independent
experiments and their S.E. Note the nearly 4-fold increase in tyrosine
phosphorylation of dimerized FAK (right bar) compared with the non-
dimerized control (left bar).
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We could not observe MAPK activation or trans-phos-
phorylation of endogenous FAK in any of the experiments
where dimerized forms of FAK were expressed. These
experiments indicate that molecular proximity, not necessa-
rily of high affinity or in a single orientation, can induce
FAK tyrosine phosphorylation. However, dimerization and
FAK phosphorylation alone were not sufficient to induce
additional biochemical signaling.
4. Discussion
This study has investigated mechanisms that can induce
FAK tyrosine phosphorylation. Since integrin-dependent
signaling via both the ERK and JNK pathways of MAPK
signaling, as well as FAK tyrosine phosphorylation, could
be induced by integrin aggregation even in the absence of
integrin receptor occupancy [17], we predicted that trans-
Fig. 7. Dimerization of FAK in a tandem orientation can induce its hyper-phosphorylation. (A) NIH 3T3 cells were transfected with the following
combinations: (1) Flag-tagged FAK fused with leucine zipper EE34; (2) Flag-tagged FAK fused with leucine zipper EE34, and HA-tagged vinculin fused with
leucine zipper RR34; (3) Flag-tagged FAK fused with leucine zippers EE34, and HA-tagged FAK; (4) Flag-tagged FAK fused with leucine zipper EE34, and
HA-tagged FAK fused with leucine zippers RR34; (5) Flag-tagged FAK fused with leucine zipper EE34, and HA-tagged FAK fused with leucine zipper EE34.
(B) Forty-eight hours following transfections by combinations 1–5 as described in panel A, the cells were trypsinized and incubated in suspension for 1 h, then
levels of FAK proteins were evaluated by Western blotting for HA, and by immunoprecipitation (I.P.) and Western blotting (W.B.) for Flag. Subsequently,
Western blotting analysis for HA or pTyr was performed on samples immunoprecipitated with anti-Flag mAb. Note that high levels of FAK tyrosine
phosphorylation were observed only when FAK molecules were dimerized in a tandem orientation with the high-affinity leucine zipper pair (panel A, line 4 and
panel B, lane 4).
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membrane or cytoplasmic aggregation of FAK could regu-
late cytoplasmic biochemical responses. Our major new
conclusions are as follows:
(a) ERK2 signaling mediated by integrin aggregation invol-
ves a transient pattern of response with a peak at 30 min,
which was mimicked exactly by transmembrane aggre-
gation of chimeras containing integrin h1, h3, and h5
cytoplasmic domains.
(b) Transmembrane aggregation of full-length FAK resulted
in ERK2 signaling with similar initial kinetics, but often
with prolonged activation.
(c) Transmembrane clustering of FAK resulted in its tyro-
sine phosphorylation, and in trans-phosphorylation of
endogenous FAK.
(d) Molecular proximity of a lower-order (dimerization) also
resulted in FAK phosphorylation. FAK phosphorylation
was induced even with relative low-affinity dimeriza-
tion, and by FAK molecules in either parallel or tandem
(head-to-tail) orientations.
These studies establish a direct mechanism for the
induction of FAK tyrosine phosphorylation and triggering
of MAPK activation in fibroblasts. Simple aggregation of
FAK close to the plane of the membrane triggers a robust
and prolonged level of ERK activation. In fact, the simple
aggregation of endogenous h1 integrins in the absence of
ligand occupancy can induce the clustering of a number
of signal transduction molecules, among them FAK [17].
This same condition results in FAK tyrosine phosphory-
lation and ERK signal propagation. Although co-cluster-
ing with integrins of nearly all signal transduction
molecules was blocked by certain selective inhibitors of
tyrosine kinase activity, such as herbimycin A, FAK still
co-accumulated readily [17]. These experiments suggested
that clustering may be an important regulator of FAK
activation. Here, we demonstrated directly that clustering
of FAK can induce both its tyrosine phosphorylation and
ERK signaling.
These studies indicate that a major regulatory mecha-
nism controlling FAK phosphorylation and other activities
may be mediated by its position within the cytoplasm
relative to other FAK molecules, but with the potential
involvement of some other kinase (e.g., Src or Pyk2 [47]).
FAK must obviously be a proximal trigger of the ERK
signaling process in this study because it was the sole
intracellular component of our FAK chimeras. We fre-
quently observed prolonged (e.g., 120 min) ERK activation
induced by FAK clustering, whereas integrin- (or integrin
tail-) induced ERK activation dissipated after 60 min. This
result suggests that integrins might cluster additional
molecules that can down-regulate ERK activation induced
by molecules such as FAK. As previously described,
integrin aggregation results in the accumulation of more
then 20 signaling and cytoskeletal molecules [17,48], and
some of them may serve as negative regulators of signal-
ing (e.g., certain phosphatases such as Shp-2 or PTP-PEST
[49,50]).
Expressing substantial levels of FAK close to the plasma
membrane in a chimera with CD2 was sufficient to activate
it in terms of constitutive tyrosine phosphorylation [32];
nevertheless, it did not stimulate MAPK activation in one
cell type [33]. Although high overexpression of FAK
constructs can promote FAK activation [36], we generally
did not observe constitutive activation of FAK phosphor-
ylation in our system of chimeras. However, we readily
induced FAK phosphorylation by expressing very high
levels of the FAK chimeras in 293 cells (B.-Z. Katz,
unpublished results). We suggest that substantial overex-
pression of membrane-associated FAK is sufficient to
permit autophosphorylation, but that activation otherwise
requires intermolecular aggregation. Overexpression may in
fact mimic aggregation due to enhanced lateral interactions
of membrane-intercalated molecules.
A transmembrane chimeric receptor system with more
modest levels of membrane expression, such as the IL-2R
system that we used in this study, combined with antibody-
coated beads, can allow tests both for the necessity of
membrane proximity and then for intermolecular clustering
in triggering downstream signaling. Both FAK autophos-
phorylation and ERK activation were minimal in our
system until we induced transmembrane clustering of
FAK chimeras by beads coated with antibodies against
the extracellular domain. Low-order molecular proximity
(dimerization) also resulted in FAK hyper-phosphorylation
in two different orientations. The fact that the induction of
FAK phosphorylation did not depend on a single orienta-
tion of the constituents of the dimers suggests that the
Fig. 8. Schematic summary and working model of data presented in this
study. Membrane translocation of small amounts of FAK does not result in
induction of tyrosine phosphorylation. Low-order molecular proximity,
namely dimerization, results in FAK hyper-phosphorylation. This response
does not require high affinity or a specific orientation of the dimer
constituents. Although dimerization is not sufficient, higher-order clustering
of FAK alone, near the plasma membrane, can induce FAK phosphor-
ylation, trans-phosphorylation of cytoplasmic FAK, and ERK2 activation.
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molecule may be flexible. The idea of ‘‘flexible’’ FAK
may be supported by the fact that Src binds to the Y397
residue at the N-terminus of FAK, but is able to phosphor-
ylate the Y925 residue in its C-terminus, thereby creating a
docking site for Grb2 [18,20]. Moreover, molecular prox-
imity may induce the formation of multimolecular com-
plexes, thereby enhancing the probability of interactions
between FAK and FAK-associated molecules and inducing
tyrosine phosphorylation. Therefore, high molecular den-
sity and intra-complex molecular flexibility may act as the
trigger for induction of cytoplasmic tyrosine phosphoryla-
tion in our experimental models, as well as within cell-
ECM attachment sites.
In conclusion, we suggest that FAK tyrosine phosphor-
ylation is regulated by its relative position and its inter-
molecular associations within the cytoplasm (Fig. 8). Low
amounts of FAK localized close to the inner face of the
plasma membrane may not be sufficient to induce its
tyrosine phosphorylation or downstream biochemical sig-
naling. Dimerization of FAK molecules can induce its
tyrosine phosphorylation, but not additional signaling
events, including ERK signaling and trans-phosphorylation
of cytoplasmic FAK. We suggest that only higher-order
molecular proximity, generated by clustering at the plasma
membrane, can induce additional biochemical signaling
such as FAK trans-phosphorylation and activation of the
ERK pathway (Fig. 8). Massive clusters of FAK molecules
may be formed during its incorporation into newly formed
focal contacts of cells attaching to extracellular matrix
substrates. We demonstrate here that molecular proximity
can trigger both FAK tyrosine phosphorylation and down-
stream biochemical events such as MAP kinase activation
and FAK trans-phosphorylation. Thus, molecular proximity
may serve as an activation trigger for FAK, in a similar
manner to other signaling molecules [43,44]. After FAK is
clustered, additional molecules such as Src may be
required for phosphorylation of FAK and then for down-
regulating activation of signaling pathways activated by
FAK, with possible involvement of other molecules such
as Shc and pp130Cas.
The multimolecular complexes associated with cell adhe-
sion sites probably contain a number of multifunctional
proteins likely to participate in many complex three-dimen-
sional molecular interactions. Experimental tests of the
functions of single molecules or of pairs of molecules by
the transmembrane clustering or dimerization approaches
described in this study should help to identify the essential
or sufficient components needed for integrin-mediated cel-
lular responses.
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